GMOVGMO U.S. Value ETF
Seeks total return.
By GMO · Launched 2024
Annual Cost
0.50%
#2,576 of 5,562 · average
Fund Size
$91M
#3,035 of 5,562 · mid-size
Return (1Y)Goal
+23.7%
Track Record
1 year
#3,910 of 5,562 · young
Performance
Total-return NAV · USDGrowth of $10,000
$12,353+23.5%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 26.7% of fund✓ well diversified
Exxon Mobil Corp
3.6%
Johnson & Johnson
3.5%
Merck & Co Inc
2.9%
Alphabet Inc
2.6%
Meta Platforms Inc
2.5%
Cisco Systems Inc
2.5%
QUALCOMM Inc
2.4%
Verizon Communications Inc
2.3%
Pfizer Inc
2.2%
Chevron Corp
2.1%
Asset allocation
Stocks
99.2%
Cash
0.8%
By sector
Financial Services
23.1%
Technology
17.1%
Healthcare
16.3%
Communication
12.3%
Consumer Cyclical
9.0%
Consumer Defensive
8.6%
Energy
7.4%
Industrials
4.5%
Other
1.8%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
10.9%Moderate
Year-on-year price swings
Max drawdown
-16.7%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks total return.
- Strategy
- Actively managed, invests primarily in U.S. equities based on financial evaluations and market dislocations. Uses proprietary quantitative methods to identify equities with positive return potential.
- Inception date
- October 28, 2024
- Fund family
- GMO
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed GMOV. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19